The emerging target KRAS G12C in genitourinary malignancies

被引：0
|
作者：
Grivas, Petros
Necchi, Andrea
Bratslavsky, Gennady
Shapiro, Oleg
Jacob, Joseph
Elvin, Julia Andrea
Vergilio, Jo-Anne
Killian, Keith
Williams, Erik
Ramkissoon, Shakti H.
Severson, Eric Allan
Hemmerich, Amanda
Schrock, Alexa Betzig
Chung, Jon
McGregor, Kimberly
Reddy, Prasanth
Alexander, Brian Michael
Sokol, Ethan
Danziger, Natalie
Ross, Jeffrey S.
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[3] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[4] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[5] Fdn Med Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
434
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC
    Brazel, Danielle
    Nagasaka, Misako
    TARGETED ONCOLOGY, 2024, 19 (03) : 297 - 301
  • [32] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Yulei Zhao
    Yonina R. Murciano-Goroff
    Jenny Y. Xue
    Agnes Ang
    Jessica Lucas
    Trang T. Mai
    Arnaud F. Da Cruz Paula
    Anne Y. Saiki
    Deanna Mohn
    Pragathi Achanta
    Ann E. Sisk
    Kanika S. Arora
    Rohan S. Roy
    Dongsung Kim
    Chuanchuan Li
    Lee P. Lim
    Mark Li
    Amber Bahr
    Brian R. Loomis
    Elisa de Stanchina
    Jorge S. Reis-Filho
    Britta Weigelt
    Michael Berger
    Gregory Riely
    Kathryn C. Arbour
    J. Russell Lipford
    Bob T. Li
    Piro Lito
    Nature, 2021, 599 : 679 - 683
  • [33] Clinical and Molecular profiling of KRAS G12C lung adenocarcinomas
    Bulusu, Venkata
    Jessop, Susan
    Paul, Sherin
    Chapman, Timothy
    Ben-Gashir, Mohamed
    Geetha, Anil
    Punnen, Geethu
    Aslam, Shahzeena
    Hutka, Margaret
    LUNG CANCER, 2023, 178 : S18 - S18
  • [34] The Research Progress of Direct KRAS G12C Mutation Inhibitors
    Yang, Ai
    Li, Min
    Fang, Mingzhi
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [35] KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
    Xiao, Annie
    Fakih, Marwan
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 199 - 206
  • [36] Small Molecule Imaging Agent for Mutant KRAS G12C
    Koch, Peter D.
    Quintana, Jeremy
    Ahmed, Maaz S.
    Kohler, Rainer H.
    Weissleder, Ralph
    ADVANCED THERAPEUTICS, 2021, 4 (05)
  • [37] Overcoming resistance to KRAS G12C inhibitors in lung cancer
    Ambrogio, Chiara
    CANCER SCIENCE, 2023, 114 : 987 - 987
  • [38] Expanding the Arsenal of Clinically Active KRAS G12C Inhibitors
    Arbour, Kathryn C.
    Lito, Piro
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2609 - +
  • [39] Breaking barriers: the latest insights into KRAS G12C inhibitors
    Attieh, Fouad
    Kourie, Hampig Raphael
    FUTURE ONCOLOGY, 2024, 20 (35) : 2685 - 2688
  • [40] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Zhao, Yulei
    Murciano-Goroff, Yonina R.
    Xue, Jenny Y.
    Ang, Agnes
    Lucas, Jessica
    Mai, Trang T.
    Da Cruz Paula, Arnaud F.
    Saiki, Anne Y.
    Mohn, Deanna
    Achanta, Pragathi
    Sisk, Ann E.
    Arora, Kanika S.
    Roy, Rohan S.
    Kim, Dongsung
    Li, Chuanchuan
    Lim, Lee P.
    Li, Mark
    Bahr, Amber
    Loomis, Brian R.
    de Stanchina, Elisa
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Berger, Michael
    Riely, Gregory
    Arbour, Kathryn C.
    Lipford, J. Russell
    Li, Bob T.
    Lito, Piro
    NATURE, 2021, 599 (7886) : 679 - +
12345